Lynwood Capital Management’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4.57M | Buy |
10,652
+114
| +1% | +$48.9K | 27.08% | 1 |
|
|
2023
Q4 | $9.25M | Sell |
10,538
-12
| -0.1% | -$10.5K | 40.71% | 1 |
|
|
2023
Q3 | $9.89M | Sell |
10,550
-9
| -0.1% | -$8.44K | 26.01% | 1 |
|
|
2023
Q2 | $10.2M | Buy |
10,559
+359
| +4% | +$346K | 12.88% | 1 |
|
|
2023
Q1 | $11.4M | Hold |
10,200
| – | – | 10.29% | 1 |
|
|
2022
Q4 | $6.69M | Buy |
10,200
+2,213
| +28% | +$1.45M | 8.04% | 1 |
|
|
2022
Q3 | $6.73M | Buy |
7,987
+3,887
| +95% | +$3.28M | 7.35% | 1 |
|
|
2022
Q2 | $3.55M | Sell |
4,100
-900
| -18% | -$779K | 3.96% | 3 |
|
|
2022
Q1 | $7.61M | Sell |
5,000
-233
| -4% | -$354K | 8.16% | 1 |
|
|
2021
Q4 | $6.5M | Buy |
+5,233
| New | +$6.5M | 6.22% | 2 |
|